Rosuvastatin is a member of the drug class of statins, used to treat hypercholesterolemia and related conditions, and to prevent cardiovascular disease. It is currently being marketed by the pharmaceutical company AstraZeneca as Crestor®.

Presentation

---

Rosuvastatin is available as Crestor in tablet form (5, 10, 20, or 40 mg) for oral administration. Tablets are pink, round or oval (40 mg), biconvex, film-coated, and imprinted with "ZD4522" and tablet strength. Japanese approval is in the dose range of 2.5 mg to 20 mg; therefore, smaller dose tablet forms might also be available outside the United States. Note that 97% of worldwide sales have been at or below the 20 mg dose.

Mechanism of action

---

See the article on statins for more details.

More on [ Rosuvastatin ]

Rosuvastatin - Twitter Search

#pharmacy FDA Panel Readies to Review Expanded Rosuvastatin Label http://bit.ly/59uRmA
bookapharmacist (Kazeem Olalekan) Tue, 15 Dec 2009 03:34:39 -0000
#pharmacy FDA Panel Readies to Review Expanded Rosuvastatin Label http://bit.ly/59uRmA
Heartwire is covering the FDA sNDA hearing for rosuvastatin (Crestor) Tuesday. Stay tuned for updates and full coverage www.theheart.org
theheartorg (Shelley Wood) Mon, 14 Dec 2009 18:19:11 -0000
Heartwire is covering the FDA sNDA hearing for rosuvastatin (Crestor) Tuesday. Stay tuned for updates and full coverage www.theheart.org
CardioBrief: FDA sets stage for Tuesday’s Crestor (rosuvastatin) advisory panel http://bit.ly/5RyANS
cardiobrief (Larry Husten) Mon, 14 Dec 2009 17:10:09 -0000
CardioBrief: FDA sets stage for Tuesday’s Crestor (rosuvastatin) advisory panel http://bit.ly/5RyANS
hehe... i'm at Taj Residency.. CME on Rosuvastatin, an edge over other Statins...
wantedwhizkid (Athul M) Sat, 12 Dec 2009 14:58:11 -0000
hehe... i'm at Taj Residency.. CME on Rosuvastatin, an edge over other Statins...
Noticing in briefing doc for rosuvastatin, HR in JUPITER for ppl w 0-1 risk factor was .91
MarilynMann (Marilyn Mann) Fri, 11 Dec 2009 22:33:56 -0000
Noticing in briefing doc for rosuvastatin, HR in JUPITER for ppl w 0-1 risk factor was .91
CardioBrief: FDA sets stage for Tuesday’s Crestor (rosuvastatin) advisory panel http://bit.ly/577YrH
cardiobrief (Larry Husten) Fri, 11 Dec 2009 19:08:47 -0000
CardioBrief: FDA sets stage for Tuesday’s Crestor (rosuvastatin) advisory panel http://bit.ly/577YrH

Subscribe to Rosuvastatin RSS feed